Immune drug-induced haemolytic anemias.
D000328:Adult; D000632:Aminopyrine / Q000009:adverse effects; D000636:Aminosalicylic Acids; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000276:immunology; D000917:Antibody Formation; D001557:Benzenesulfonates / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D002859:Chromium Isotopes; D004802:Eosinophilia; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006801:Humans; D007074:Immunoglobulin G; D007306:Insecticides; D007970:Leukopenia; D008875:Middle Aged; D009539:Nicotinic Acids / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects; D010615:Phenacetin / Q000009:adverse effects; D011803:Quinine / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects
D000636:Aminosalicylic Acids; D001557:Benzenesulfonates; D002859:Chromium Isotopes; D007074:Immunoglobulin G; D007306:Insecticides; D009539:Nicotinic Acids; D010406:Penicillins; D013449:Sulfonamides; D000632:Aminopyrine; D011803:Quinine; D010615:Phenacetin; D002746:Chlorpromazine